Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging
Go back to Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) | Delayed: 57.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.56 | 52 Week High | $77.80 | |||
| Open | $3.73 | 52 Week Low | $37.38 | |||
| Day High | $57.56 | P/E | N/A | |||
| Day Low | $57.56 | EPS | $-0.35 | |||
| Volume | 15 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.85 +0.70 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.15 | 52 Week High | $44.76 | |||
| Open | $45.26 | 52 Week Low | $36.81 | |||
| Day High | $46.11 | P/E | N/A | |||
| Day Low | $45.25 | EPS | $0.00 | |||
| Volume | 1,860,731 | |||||

